DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Citigroup Initiates Coverage On Neurocrine Biosciences with Buy Rating, Announces $124 Price Target

Citigroup analyst Neena Bitritto-Garg initiates coverage on Neurocrine Biosciences (NASDAQ:NBIX) with a Buy rating and a $124 price target.

Benzinga · 03/06/2020 10:01

Citigroup analyst Neena Bitritto-Garg initiates coverage on Neurocrine Biosciences (NASDAQ:NBIX) with a Buy rating and a $124 price target.